Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 2:24 AM
Ignite Modification Date: 2025-12-26 @ 12:57 AM
NCT ID: NCT02429934
Description: We used clinicaltrials.gov definitions
Frequency Threshold: 1
Time Frame: Adverse events were collected for 20 weeks after initial dose (visit 1)
Study: NCT02429934
Study Brief: Abatacept for SLE Arthritis (IM101-330)
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Abatacept abatacept: 125mg injected subcutaneously weekly for 16 weeks 0 None 1 15 6 15 View
Placebo Placebo subcutaneous injection weekly for 16 weeks 0 None 0 13 3 13 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
flare of lupus nephritis SYSTEMATIC_ASSESSMENT Renal and urinary disorders None View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
skin reaction at injection site SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders None View